Free shipping on all orders over $ 500

Tasosartan

Cat. No. M3790
Tasosartan Structure
Synonym:

WAY-ANA 756

Size Price Availability Quantity
2mg USD 99  USD99 In stock
5mg USD 147  USD147 In stock
10mg USD 235  USD235 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tasosartan blocks the renin-angiotensin-aldosterone system (RAAS) at the level of the AT1 receptor that mediates most, if not all, of the important actions of Ang II. Tasosartan binds reversibly to the AT1 receptors in vascular smooth muscle and the adrenal gland. As angiotensin II is a vasoconstrictor, which also stimulates the synthesis and release of aldosterone, blockage of its effects results in decreases in systemic vascular resistance. AT1 receptor antagonists avoid the nonspecificity of the Ang I converting enzyme (ACE) inhibitors. Antagonism of the AT1 receptor with tasosartan reduces blood pressure at rest and during submaximal exercise but not during maximal exercise. The reduced blood pressure was associated with a reduced total peripheral resistance during submaximal exercise but not at rest in the control condition while cardiac output was unaltered in either condition. Lastly, tasosartan did not impair working capacity as measured from peak workload and oxygen uptake.

Customer Product Validations & Biological Datas
Source J Pharmacol Exp Ther (2000). Figure 4. Tasosartan
Method receptor binding assay
Cell Lines vascular smooth muscle cell
Concentrations
Incubation Time 4 to 6 h
Results In the receptor binding assay, the addition of 6.25% human plasma to the buffer (final concentration of plasma protein 0.4%) resulted in small but significant differences in the affinity of tasosartan for the AT1 receptor (IC50 shifted from 2.0 to 9.5 nM), whereas the same procedure shifted IC50 for enoltasosartan from 0.4 to 340 nM
Source J Pharmacol Exp Ther (2000). Figure 2. Tasosartan
Method oral administration
Cell Lines
Concentrations 50 mg
Incubation Time 8.0 h
Results Tasosartan was rapidly absorbed after oral administration and Tmax 30 min (with Cmax of 1596 ± 250 ng/ml) was observed in all subjects (n=12).
Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models mice
Formulation
Dosages 50 mg/kg
Administration p.o. or i.v.
Chemical Information
Molecular Weight 411.46
Formula C23H21N7O
CAS Number 145733-36-4
Solubility (25°C) DMSO 10 mM
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Elokdah HM, et al. Bioorg Med Chem Lett. Novel human metabolites of the angiotensin-II antagonist tasosartan and their pharmacological effects.

[2] Maillard MP, et al. J Pharmacol Exp Ther. Tasosartan, enoltasosartan, and angiotensin II receptor blockade: the confounding role of protein binding.

[3] Dina R, et al. Am J Health Syst Pharm. Angiotensin II-receptor antagonists: an overview.

[4] Andrawis NS, et al. J Clin Pharmacol. A pharmacokinetic and pharmacodynamic study of the potential drug interaction between tasosartan and atenolol in patients with stage 1 and 2 essential hypertension.

[5] Rhéaume C, et al. J Hypertens. Effects of angiotensin antagonism with tasosartan on regional and systemic haemodynamics in hypertensive patients.

Related Angiotensin Receptor Products
TRV055 hydrochloride

TRV055 hydrochloride, a G-protein-biased agonist, is a Gq-biased ligand of the angiotensin II receptor type 1 (AT1R). TRV055 hydrochloride is efficacious in stimulating cellular Gq-mediated signaling.

(Sar1, Ile4, 8)-Angiotensin II

(Sar1,Ile4,8)-Angiotensin II is a functionally selective angiotensin II type 1 receptor (AT1R) agonist.

TRV055

TRV055, a G-protein-biased agonist, is a Gq-biased ligand of the angiotensin II receptor type 1 (AT1R).

Alamandine

Alamandine, a member of the renin-angiotensin system (RAS), a vasoactive peptide, is an endogenous ligand of the G protein-coupled receptor MrgD.

(Sar1)-Angiotensin II

(Sar1)-Angiotensin II, an analogue of Angiotensin II, is a specific agonist of angiotensin AT1 receptor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Tasosartan, WAY-ANA 756 supplier, Angiotensin Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.